West Family Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
West Family Investments's BMY Position: Q1 2026 in Review
West Family Investments opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 3,528 shares worth $214K. The stake represents 0.08% of the portfolio and ranks #236 among its holdings. This is a return to the name: West Family Investments previously reported a position in BMY as recently as Q3 2025.
West Family Investments first reported a position in BMY in Q2 2021 and has held it in 17 quarters since. The position peaked at $882K in Q4 2022. 2,522 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- West Family Investments held 3,528 shares of Bristol-Myers Squibb worth $214K as of Q1 2026.
- Bristol-Myers Squibb was a new West Family Investments position in Q1 2026.
- Bristol-Myers Squibb made up 0.08% of West Family Investments's portfolio in Q1 2026, its #236 holding.
- West Family Investments first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 17 quarters since.
- West Family Investments's Bristol-Myers Squibb position peaked at $882K in Q4 2022.
- 2,522 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on West Family Investments's 13F filing for Q1 2026, filed 7 May 2026.